感染症POC診断のグローバル市場インサイト・予測（～2028年）

• 英文タイトル：Global Infectious Disease POC Diagnostic Market Insights, Forecast to 2028

• レポートコード：QY2207E09587 • 出版社/出版日：QYResearch / 2022年7月 • レポート形態：英文、PDF、114ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療機器

• 販売価格（消費税別）

Single User	￥725,200 (USD4,900)	▷ お問い合わせ
Multi User	￥1,087,800 (USD7,350)	▷ お問い合わせ
Enterprise License	￥1,450,400 (USD9,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

新型コロナウイルス感染症のパンデミックにより、世界の感染症POC診断の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に感染症POC診断の世界市場のxxx％を占める「イムノクロマトグラフィー」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「病院ベッドサイド」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。 中国の感染症POC診断の市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパの感染症POC診断市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパの感染症POC診断市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。 感染症POC診断のグローバル主要メーカーには、F. Hoffmann-La Roche、Thermo Fisher Scientific、Abbott Laboratories、Quest Diagnostics、BD、bioMérieux、Cardinal Health、Cepheid、Trinity Biotech、Quidel Corporation、Bio-Rad Laboratoriesなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 感染症POC診断市場は、種類と用途によって区分されます。世界の感染症POC診断市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。 【種類別セグメント】 イムノクロマトグラフィー、凝集反応、フロースルー検査、分子診断、その他 【用途別セグメント】 病院ベッドサイド、緊急医療・小売クリニック、家庭・自己診断、その他 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - 感染症POC診断製品概要 - 種類別市場（イムノクロマトグラフィー、凝集反応、フロースルー検査、分子診断、その他） - 用途別市場（病院ベッドサイド、緊急医療・小売クリニック、家庭・自己診断、その他） - 調査の目的 ・エグゼクティブサマリー - 世界の感染症POC診断販売量予測2017-2028 - 世界の感染症POC診断売上予測2017-2028 - 感染症POC診断の地域別販売量 - 感染症POC診断の地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別感染症POC診断販売量 - 主要メーカー別感染症POC診断売上 - 主要メーカー別感染症POC診断価格 - 競争状況の分析 - 企業M&A動向 ・種類別市場規模（イムノクロマトグラフィー、凝集反応、フロースルー検査、分子診断、その他） - 感染症POC診断の種類別販売量 - 感染症POC診断の種類別売上 - 感染症POC診断の種類別価格 ・用途別市場規模（病院ベッドサイド、緊急医療・小売クリニック、家庭・自己診断、その他） - 感染症POC診断の用途別販売量 - 感染症POC診断の用途別売上 - 感染症POC診断の用途別価格 ・北米市場 - 北米の感染症POC診断市場規模（種類別、用途別） - 主要国別の感染症POC診断市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパの感染症POC診断市場規模（種類別、用途別） - 主要国別の感染症POC診断市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋の感染症POC診断市場規模（種類別、用途別） - 主要国別の感染症POC診断市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米の感染症POC診断市場規模（種類別、用途別） - 主要国別の感染症POC診断市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカの感染症POC診断市場規模（種類別、用途別） - 主要国別の感染症POC診断市場規模（トルコ、サウジアラビア） ・企業情報 F. Hoffmann-La Roche、Thermo Fisher Scientific、Abbott Laboratories、Quest Diagnostics、BD、bioMérieux、Cardinal Health、Cepheid、Trinity Biotech、Quidel Corporation、Bio-Rad Laboratories ・産業チェーン及び販売チャネル分析 - 感染症POC診断の産業チェーン分析 - 感染症POC診断の原材料 - 感染症POC診断の生産プロセス - 感染症POC診断の販売及びマーケティング - 感染症POC診断の主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - 感染症POC診断の産業動向 - 感染症POC診断のマーケットドライバー - 感染症POC診断の課題 - 感染症POC診断の阻害要因 ・主な調査結果

Diagnostic tests are important for diagnosing diseases and for improving global health. Traditional diagnoses ofinfectious disease resulted in inaccurate results and were time-consuming.This flaw led to the emergence of rapid.accurate, and portable point-of-care testing products in the market. POC testing enables faster diagnosis of infectious disease near the patient site providing quick results、 Severalresearchers are now focused on the development of multiplex point-of-care diagnostic technologies. These MPOCTdevices consist of hybridization papers, array settings, bead technology, or microftuidic systems that reduce the assaysteps and provide diagnosis results in 15-30 minutes.
Market Analysis and Insights: Global Infectious Disease POC Diagnostic Market
Due to the COVID-19 pandemic, the global Infectious Disease POC Diagnostic market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, Lateral Flow Immunoassay accounting for % of the Infectious Disease POC Diagnostic global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hospital Bedside segment is altered to an % CAGR throughout this forecast period.
China Infectious Disease POC Diagnostic market size is valued at US$ million in 2021, while the US and Europe Infectious Disease POC Diagnostic are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Infectious Disease POC Diagnostic landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
The global key manufacturers of Infectious Disease POC Diagnostic include F. Hoffmann-La Roche, Thermo Fisher Scientific, Abbott Laboratories, Quest Diagnostics, BD, bioMérieux, Cardinal Health, Cepheid and Trinity Biotech, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Infectious Disease POC Diagnostic Scope and Segment
Infectious Disease POC Diagnostic market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Infectious Disease POC Diagnostic market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Lateral Flow Immunoassay
Agglutination Test
Flow-Through Test
Molecular Diagnostics
Others
Segment by Application
Hospital Bedside
Urgent Care and Retail Clinics
Home and Self-Testing
Others
By Company
F. Hoffmann-La Roche
Thermo Fisher Scientific
Abbott Laboratories
Quest Diagnostics
BD
bioMérieux
Cardinal Health
Cepheid
Trinity Biotech
Quidel Corporation
Bio-Rad Laboratories
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE

レポート目次

---

1 Study Coverage
1.1 Infectious Disease POC Diagnostic Product Introduction
1.2 Market by Type
1.2.1 Global Infectious Disease POC Diagnostic Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Lateral Flow Immunoassay
1.2.3 Agglutination Test
1.2.4 Flow-Through Test
1.2.5 Molecular Diagnostics
1.2.6 Others
1.3 Market by Application
1.3.1 Global Infectious Disease POC Diagnostic Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital Bedside
1.3.3 Urgent Care and Retail Clinics
1.3.4 Home and Self-Testing
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Infectious Disease POC Diagnostic Sales Estimates and Forecasts 2017-2028
2.2 Global Infectious Disease POC Diagnostic Revenue Estimates and Forecasts 2017-2028
2.3 Global Infectious Disease POC Diagnostic Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Infectious Disease POC Diagnostic Sales by Region
2.4.1 Global Infectious Disease POC Diagnostic Sales by Region (2017-2022)
2.4.2 Global Sales Infectious Disease POC Diagnostic by Region (2023-2028)
2.5 Global Infectious Disease POC Diagnostic Revenue by Region
2.5.1 Global Infectious Disease POC Diagnostic Revenue by Region (2017-2022)
2.5.2 Global Infectious Disease POC Diagnostic Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Infectious Disease POC Diagnostic Sales by Manufacturers
3.1.1 Global Top Infectious Disease POC Diagnostic Manufacturers by Sales (2017-2022)
3.1.2 Global Infectious Disease POC Diagnostic Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Infectious Disease POC Diagnostic in 2021
3.2 Global Infectious Disease POC Diagnostic Revenue by Manufacturers
3.2.1 Global Infectious Disease POC Diagnostic Revenue by Manufacturers (2017-2022)
3.2.2 Global Infectious Disease POC Diagnostic Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Infectious Disease POC Diagnostic Revenue in 2021
3.3 Global Infectious Disease POC Diagnostic Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Infectious Disease POC Diagnostic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Infectious Disease POC Diagnostic Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Infectious Disease POC Diagnostic Sales by Type
4.1.1 Global Infectious Disease POC Diagnostic Historical Sales by Type (2017-2022)
4.1.2 Global Infectious Disease POC Diagnostic Forecasted Sales by Type (2023-2028)
4.1.3 Global Infectious Disease POC Diagnostic Sales Market Share by Type (2017-2028)
4.2 Global Infectious Disease POC Diagnostic Revenue by Type
4.2.1 Global Infectious Disease POC Diagnostic Historical Revenue by Type (2017-2022)
4.2.2 Global Infectious Disease POC Diagnostic Forecasted Revenue by Type (2023-2028)
4.2.3 Global Infectious Disease POC Diagnostic Revenue Market Share by Type (2017-2028)
4.3 Global Infectious Disease POC Diagnostic Price by Type
4.3.1 Global Infectious Disease POC Diagnostic Price by Type (2017-2022)
4.3.2 Global Infectious Disease POC Diagnostic Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Infectious Disease POC Diagnostic Sales by Application
5.1.1 Global Infectious Disease POC Diagnostic Historical Sales by Application (2017-2022)
5.1.2 Global Infectious Disease POC Diagnostic Forecasted Sales by Application (2023-2028)
5.1.3 Global Infectious Disease POC Diagnostic Sales Market Share by Application (2017-2028)
5.2 Global Infectious Disease POC Diagnostic Revenue by Application
5.2.1 Global Infectious Disease POC Diagnostic Historical Revenue by Application (2017-2022)
5.2.2 Global Infectious Disease POC Diagnostic Forecasted Revenue by Application (2023-2028)
5.2.3 Global Infectious Disease POC Diagnostic Revenue Market Share by Application (2017-2028)
5.3 Global Infectious Disease POC Diagnostic Price by Application
5.3.1 Global Infectious Disease POC Diagnostic Price by Application (2017-2022)
5.3.2 Global Infectious Disease POC Diagnostic Price Forecast by Application (2023-2028)
6 North America
6.1 North America Infectious Disease POC Diagnostic Market Size by Type
6.1.1 North America Infectious Disease POC Diagnostic Sales by Type (2017-2028)
6.1.2 North America Infectious Disease POC Diagnostic Revenue by Type (2017-2028)
6.2 North America Infectious Disease POC Diagnostic Market Size by Application
6.2.1 North America Infectious Disease POC Diagnostic Sales by Application (2017-2028)
6.2.2 North America Infectious Disease POC Diagnostic Revenue by Application (2017-2028)
6.3 North America Infectious Disease POC Diagnostic Market Size by Country
6.3.1 North America Infectious Disease POC Diagnostic Sales by Country (2017-2028)
6.3.2 North America Infectious Disease POC Diagnostic Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Infectious Disease POC Diagnostic Market Size by Type
7.1.1 Europe Infectious Disease POC Diagnostic Sales by Type (2017-2028)
7.1.2 Europe Infectious Disease POC Diagnostic Revenue by Type (2017-2028)
7.2 Europe Infectious Disease POC Diagnostic Market Size by Application
7.2.1 Europe Infectious Disease POC Diagnostic Sales by Application (2017-2028)
7.2.2 Europe Infectious Disease POC Diagnostic Revenue by Application (2017-2028)
7.3 Europe Infectious Disease POC Diagnostic Market Size by Country
7.3.1 Europe Infectious Disease POC Diagnostic Sales by Country (2017-2028)
7.3.2 Europe Infectious Disease POC Diagnostic Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Infectious Disease POC Diagnostic Market Size by Type
8.1.1 Asia Pacific Infectious Disease POC Diagnostic Sales by Type (2017-2028)
8.1.2 Asia Pacific Infectious Disease POC Diagnostic Revenue by Type (2017-2028)
8.2 Asia Pacific Infectious Disease POC Diagnostic Market Size by Application
8.2.1 Asia Pacific Infectious Disease POC Diagnostic Sales by Application (2017-2028)
8.2.2 Asia Pacific Infectious Disease POC Diagnostic Revenue by Application (2017-2028)
8.3 Asia Pacific Infectious Disease POC Diagnostic Market Size by Region
8.3.1 Asia Pacific Infectious Disease POC Diagnostic Sales by Region (2017-2028)
8.3.2 Asia Pacific Infectious Disease POC Diagnostic Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Infectious Disease POC Diagnostic Market Size by Type
9.1.1 Latin America Infectious Disease POC Diagnostic Sales by Type (2017-2028)
9.1.2 Latin America Infectious Disease POC Diagnostic Revenue by Type (2017-2028)
9.2 Latin America Infectious Disease POC Diagnostic Market Size by Application
9.2.1 Latin America Infectious Disease POC Diagnostic Sales by Application (2017-2028)
9.2.2 Latin America Infectious Disease POC Diagnostic Revenue by Application (2017-2028)
9.3 Latin America Infectious Disease POC Diagnostic Market Size by Country
9.3.1 Latin America Infectious Disease POC Diagnostic Sales by Country (2017-2028)
9.3.2 Latin America Infectious Disease POC Diagnostic Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
9.3.6 Colombia
10 Middle East and Africa
10.1 Middle East and Africa Infectious Disease POC Diagnostic Market Size by Type
10.1.1 Middle East and Africa Infectious Disease POC Diagnostic Sales by Type (2017-2028)
10.1.2 Middle East and Africa Infectious Disease POC Diagnostic Revenue by Type (2017-2028)
10.2 Middle East and Africa Infectious Disease POC Diagnostic Market Size by Application
10.2.1 Middle East and Africa Infectious Disease POC Diagnostic Sales by Application (2017-2028)
10.2.2 Middle East and Africa Infectious Disease POC Diagnostic Revenue by Application (2017-2028)
10.3 Middle East and Africa Infectious Disease POC Diagnostic Market Size by Country
10.3.1 Middle East and Africa Infectious Disease POC Diagnostic Sales by Country (2017-2028)
10.3.2 Middle East and Africa Infectious Disease POC Diagnostic Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 F. Hoffmann-La Roche
11.1.1 F. Hoffmann-La Roche Corporation Information
11.1.2 F. Hoffmann-La Roche Overview
11.1.3 F. Hoffmann-La Roche Infectious Disease POC Diagnostic Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 F. Hoffmann-La Roche Infectious Disease POC Diagnostic Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 F. Hoffmann-La Roche Recent Developments
11.2 Thermo Fisher Scientific
11.2.1 Thermo Fisher Scientific Corporation Information
11.2.2 Thermo Fisher Scientific Overview
11.2.3 Thermo Fisher Scientific Infectious Disease POC Diagnostic Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Thermo Fisher Scientific Infectious Disease POC Diagnostic Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Thermo Fisher Scientific Recent Developments
11.3 Abbott Laboratories
11.3.1 Abbott Laboratories Corporation Information
11.3.2 Abbott Laboratories Overview
11.3.3 Abbott Laboratories Infectious Disease POC Diagnostic Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Abbott Laboratories Infectious Disease POC Diagnostic Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Abbott Laboratories Recent Developments
11.4 Quest Diagnostics
11.4.1 Quest Diagnostics Corporation Information
11.4.2 Quest Diagnostics Overview
11.4.3 Quest Diagnostics Infectious Disease POC Diagnostic Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Quest Diagnostics Infectious Disease POC Diagnostic Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Quest Diagnostics Recent Developments
11.5 BD
11.5.1 BD Corporation Information
11.5.2 BD Overview
11.5.3 BD Infectious Disease POC Diagnostic Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 BD Infectious Disease POC Diagnostic Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 BD Recent Developments
11.6 bioMérieux
11.6.1 bioMérieux Corporation Information
11.6.2 bioMérieux Overview
11.6.3 bioMérieux Infectious Disease POC Diagnostic Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 bioMérieux Infectious Disease POC Diagnostic Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 bioMérieux Recent Developments
11.7 Cardinal Health
11.7.1 Cardinal Health Corporation Information
11.7.2 Cardinal Health Overview
11.7.3 Cardinal Health Infectious Disease POC Diagnostic Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Cardinal Health Infectious Disease POC Diagnostic Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Cardinal Health Recent Developments
11.8 Cepheid
11.8.1 Cepheid Corporation Information
11.8.2 Cepheid Overview
11.8.3 Cepheid Infectious Disease POC Diagnostic Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Cepheid Infectious Disease POC Diagnostic Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Cepheid Recent Developments
11.9 Trinity Biotech
11.9.1 Trinity Biotech Corporation Information
11.9.2 Trinity Biotech Overview
11.9.3 Trinity Biotech Infectious Disease POC Diagnostic Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Trinity Biotech Infectious Disease POC Diagnostic Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Trinity Biotech Recent Developments
11.10 Quidel Corporation
11.10.1 Quidel Corporation Corporation Information
11.10.2 Quidel Corporation Overview
11.10.3 Quidel Corporation Infectious Disease POC Diagnostic Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Quidel Corporation Infectious Disease POC Diagnostic Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Quidel Corporation Recent Developments
11.11 Bio-Rad Laboratories
11.11.1 Bio-Rad Laboratories Corporation Information
11.11.2 Bio-Rad Laboratories Overview
11.11.3 Bio-Rad Laboratories Infectious Disease POC Diagnostic Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Bio-Rad Laboratories Infectious Disease POC Diagnostic Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Bio-Rad Laboratories Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Infectious Disease POC Diagnostic Industry Chain Analysis
12.2 Infectious Disease POC Diagnostic Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Infectious Disease POC Diagnostic Production Mode & Process
12.4 Infectious Disease POC Diagnostic Sales and Marketing
12.4.1 Infectious Disease POC Diagnostic Sales Channels
12.4.2 Infectious Disease POC Diagnostic Distributors
12.5 Infectious Disease POC Diagnostic Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Infectious Disease POC Diagnostic Industry Trends
13.2 Infectious Disease POC Diagnostic Market Drivers
13.3 Infectious Disease POC Diagnostic Market Challenges
13.4 Infectious Disease POC Diagnostic Market Restraints
14 Key Findings in The Global Infectious Disease POC Diagnostic Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Tables
Table 1. Global Infectious Disease POC Diagnostic Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Lateral Flow Immunoassay
Table 3. Major Manufacturers of Agglutination Test
Table 4. Major Manufacturers of Flow-Through Test
Table 5. Major Manufacturers of Molecular Diagnostics
Table 6. Major Manufacturers of Others
Table 7. Global Infectious Disease POC Diagnostic Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 8. Global Infectious Disease POC Diagnostic Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 9. Global Infectious Disease POC Diagnostic Sales by Region (2017-2022) & (K Units)
Table 10. Global Infectious Disease POC Diagnostic Sales Market Share by Region (2017-2022)
Table 11. Global Infectious Disease POC Diagnostic Sales by Region (2023-2028) & (K Units)
Table 12. Global Infectious Disease POC Diagnostic Sales Market Share by Region (2023-2028)
Table 13. Global Infectious Disease POC Diagnostic Revenue by Region (2017-2022) & (US$ Million)
Table 14. Global Infectious Disease POC Diagnostic Revenue Market Share by Region (2017-2022)
Table 15. Global Infectious Disease POC Diagnostic Revenue by Region (2023-2028) & (US$ Million)
Table 16. Global Infectious Disease POC Diagnostic Revenue Market Share by Region (2023-2028)
Table 17. Global Infectious Disease POC Diagnostic Sales by Manufacturers (2017-2022) & (K Units)
Table 18. Global Infectious Disease POC Diagnostic Sales Share by Manufacturers (2017-2022)
Table 19. Global Infectious Disease POC Diagnostic Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 20. Global Infectious Disease POC Diagnostic Revenue Share by Manufacturers (2017-2022)
Table 21. Infectious Disease POC Diagnostic Price by Manufacturers (2017-2022) &(US$/Unit)
Table 22. Global Infectious Disease POC Diagnostic Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 23. Global Infectious Disease POC Diagnostic by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Infectious Disease POC Diagnostic as of 2021)
Table 24. Infectious Disease POC Diagnostic Manufacturing Base Distribution and Headquarters
Table 25. Manufacturers Infectious Disease POC Diagnostic Product Offered
Table 26. Date of Manufacturers Enter into Infectious Disease POC Diagnostic Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Infectious Disease POC Diagnostic Sales by Type (2017-2022) & (K Units)
Table 29. Global Infectious Disease POC Diagnostic Sales by Type (2023-2028) & (K Units)
Table 30. Global Infectious Disease POC Diagnostic Sales Share by Type (2017-2022)
Table 31. Global Infectious Disease POC Diagnostic Sales Share by Type (2023-2028)
Table 32. Global Infectious Disease POC Diagnostic Revenue by Type (2017-2022) & (US$ Million)
Table 33. Global Infectious Disease POC Diagnostic Revenue by Type (2023-2028) & (US$ Million)
Table 34. Global Infectious Disease POC Diagnostic Revenue Share by Type (2017-2022)
Table 35. Global Infectious Disease POC Diagnostic Revenue Share by Type (2023-2028)
Table 36. Infectious Disease POC Diagnostic Price by Type (2017-2022) & (US$/Unit)
Table 37. Global Infectious Disease POC Diagnostic Price Forecast by Type (2023-2028) & (US$/Unit)
Table 38. Global Infectious Disease POC Diagnostic Sales by Application (2017-2022) & (K Units)
Table 39. Global Infectious Disease POC Diagnostic Sales by Application (2023-2028) & (K Units)
Table 40. Global Infectious Disease POC Diagnostic Sales Share by Application (2017-2022)
Table 41. Global Infectious Disease POC Diagnostic Sales Share by Application (2023-2028)
Table 42. Global Infectious Disease POC Diagnostic Revenue by Application (2017-2022) & (US$ Million)
Table 43. Global Infectious Disease POC Diagnostic Revenue by Application (2023-2028) & (US$ Million)
Table 44. Global Infectious Disease POC Diagnostic Revenue Share by Application (2017-2022)
Table 45. Global Infectious Disease POC Diagnostic Revenue Share by Application (2023-2028)
Table 46. Infectious Disease POC Diagnostic Price by Application (2017-2022) & (US$/Unit)
Table 47. Global Infectious Disease POC Diagnostic Price Forecast by Application (2023-2028) & (US$/Unit)
Table 48. North America Infectious Disease POC Diagnostic Sales by Type (2017-2022) & (K Units)
Table 49. North America Infectious Disease POC Diagnostic Sales by Type (2023-2028) & (K Units)
Table 50. North America Infectious Disease POC Diagnostic Revenue by Type (2017-2022) & (US$ Million)
Table 51. North America Infectious Disease POC Diagnostic Revenue by Type (2023-2028) & (US$ Million)
Table 52. North America Infectious Disease POC Diagnostic Sales by Application (2017-2022) & (K Units)
Table 53. North America Infectious Disease POC Diagnostic Sales by Application (2023-2028) & (K Units)
Table 54. North America Infectious Disease POC Diagnostic Revenue by Application (2017-2022) & (US$ Million)
Table 55. North America Infectious Disease POC Diagnostic Revenue by Application (2023-2028) & (US$ Million)
Table 56. North America Infectious Disease POC Diagnostic Sales by Country (2017-2022) & (K Units)
Table 57. North America Infectious Disease POC Diagnostic Sales by Country (2023-2028) & (K Units)
Table 58. North America Infectious Disease POC Diagnostic Revenue by Country (2017-2022) & (US$ Million)
Table 59. North America Infectious Disease POC Diagnostic Revenue by Country (2023-2028) & (US$ Million)
Table 60. Europe Infectious Disease POC Diagnostic Sales by Type (2017-2022) & (K Units)
Table 61. Europe Infectious Disease POC Diagnostic Sales by Type (2023-2028) & (K Units)
Table 62. Europe Infectious Disease POC Diagnostic Revenue by Type (2017-2022) & (US$ Million)
Table 63. Europe Infectious Disease POC Diagnostic Revenue by Type (2023-2028) & (US$ Million)
Table 64. Europe Infectious Disease POC Diagnostic Sales by Application (2017-2022) & (K Units)
Table 65. Europe Infectious Disease POC Diagnostic Sales by Application (2023-2028) & (K Units)
Table 66. Europe Infectious Disease POC Diagnostic Revenue by Application (2017-2022) & (US$ Million)
Table 67. Europe Infectious Disease POC Diagnostic Revenue by Application (2023-2028) & (US$ Million)
Table 68. Europe Infectious Disease POC Diagnostic Sales by Country (2017-2022) & (K Units)
Table 69. Europe Infectious Disease POC Diagnostic Sales by Country (2023-2028) & (K Units)
Table 70. Europe Infectious Disease POC Diagnostic Revenue by Country (2017-2022) & (US$ Million)
Table 71. Europe Infectious Disease POC Diagnostic Revenue by Country (2023-2028) & (US$ Million)
Table 72. Asia Pacific Infectious Disease POC Diagnostic Sales by Type (2017-2022) & (K Units)
Table 73. Asia Pacific Infectious Disease POC Diagnostic Sales by Type (2023-2028) & (K Units)
Table 74. Asia Pacific Infectious Disease POC Diagnostic Revenue by Type (2017-2022) & (US$ Million)
Table 75. Asia Pacific Infectious Disease POC Diagnostic Revenue by Type (2023-2028) & (US$ Million)
Table 76. Asia Pacific Infectious Disease POC Diagnostic Sales by Application (2017-2022) & (K Units)
Table 77. Asia Pacific Infectious Disease POC Diagnostic Sales by Application (2023-2028) & (K Units)
Table 78. Asia Pacific Infectious Disease POC Diagnostic Revenue by Application (2017-2022) & (US$ Million)
Table 79. Asia Pacific Infectious Disease POC Diagnostic Revenue by Application (2023-2028) & (US$ Million)
Table 80. Asia Pacific Infectious Disease POC Diagnostic Sales by Region (2017-2022) & (K Units)
Table 81. Asia Pacific Infectious Disease POC Diagnostic Sales by Region (2023-2028) & (K Units)
Table 82. Asia Pacific Infectious Disease POC Diagnostic Revenue by Region (2017-2022) & (US$ Million)
Table 83. Asia Pacific Infectious Disease POC Diagnostic Revenue by Region (2023-2028) & (US$ Million)
Table 84. Latin America Infectious Disease POC Diagnostic Sales by Type (2017-2022) & (K Units)
Table 85. Latin America Infectious Disease POC Diagnostic Sales by Type (2023-2028) & (K Units)
Table 86. Latin America Infectious Disease POC Diagnostic Revenue by Type (2017-2022) & (US$ Million)
Table 87. Latin America Infectious Disease POC Diagnostic Revenue by Type (2023-2028) & (US$ Million)
Table 88. Latin America Infectious Disease POC Diagnostic Sales by Application (2017-2022) & (K Units)
Table 89. Latin America Infectious Disease POC Diagnostic Sales by Application (2023-2028) & (K Units)
Table 90. Latin America Infectious Disease POC Diagnostic Revenue by Application (2017-2022) & (US$ Million)
Table 91. Latin America Infectious Disease POC Diagnostic Revenue by Application (2023-2028) & (US$ Million)
Table 92. Latin America Infectious Disease POC Diagnostic Sales by Country (2017-2022) & (K Units)
Table 93. Latin America Infectious Disease POC Diagnostic Sales by Country (2023-2028) & (K Units)
Table 94. Latin America Infectious Disease POC Diagnostic Revenue by Country (2017-2022) & (US$ Million)
Table 95. Latin America Infectious Disease POC Diagnostic Revenue by Country (2023-2028) & (US$ Million)
Table 96. Middle East and Africa Infectious Disease POC Diagnostic Sales by Type (2017-2022) & (K Units)
Table 97. Middle East and Africa Infectious Disease POC Diagnostic Sales by Type (2023-2028) & (K Units)
Table 98. Middle East and Africa Infectious Disease POC Diagnostic Revenue by Type (2017-2022) & (US$ Million)
Table 99. Middle East and Africa Infectious Disease POC Diagnostic Revenue by Type (2023-2028) & (US$ Million)
Table 100. Middle East and Africa Infectious Disease POC Diagnostic Sales by Application (2017-2022) & (K Units)
Table 101. Middle East and Africa Infectious Disease POC Diagnostic Sales by Application (2023-2028) & (K Units)
Table 102. Middle East and Africa Infectious Disease POC Diagnostic Revenue by Application (2017-2022) & (US$ Million)
Table 103. Middle East and Africa Infectious Disease POC Diagnostic Revenue by Application (2023-2028) & (US$ Million)
Table 104. Middle East and Africa Infectious Disease POC Diagnostic Sales by Country (2017-2022) & (K Units)
Table 105. Middle East and Africa Infectious Disease POC Diagnostic Sales by Country (2023-2028) & (K Units)
Table 106. Middle East and Africa Infectious Disease POC Diagnostic Revenue by Country (2017-2022) & (US$ Million)
Table 107. Middle East and Africa Infectious Disease POC Diagnostic Revenue by Country (2023-2028) & (US$ Million)
Table 108. F. Hoffmann-La Roche Corporation Information
Table 109. F. Hoffmann-La Roche Description and Major Businesses
Table 110. F. Hoffmann-La Roche Infectious Disease POC Diagnostic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 111. F. Hoffmann-La Roche Infectious Disease POC Diagnostic Product Model Numbers, Pictures, Descriptions and Specifications
Table 112. F. Hoffmann-La Roche Recent Developments
Table 113. Thermo Fisher Scientific Corporation Information
Table 114. Thermo Fisher Scientific Description and Major Businesses
Table 115. Thermo Fisher Scientific Infectious Disease POC Diagnostic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 116. Thermo Fisher Scientific Infectious Disease POC Diagnostic Product Model Numbers, Pictures, Descriptions and Specifications
Table 117. Thermo Fisher Scientific Recent Developments
Table 118. Abbott Laboratories Corporation Information
Table 119. Abbott Laboratories Description and Major Businesses
Table 120. Abbott Laboratories Infectious Disease POC Diagnostic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 121. Abbott Laboratories Infectious Disease POC Diagnostic Product Model Numbers, Pictures, Descriptions and Specifications
Table 122. Abbott Laboratories Recent Developments
Table 123. Quest Diagnostics Corporation Information
Table 124. Quest Diagnostics Description and Major Businesses
Table 125. Quest Diagnostics Infectious Disease POC Diagnostic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 126. Quest Diagnostics Infectious Disease POC Diagnostic Product Model Numbers, Pictures, Descriptions and Specifications
Table 127. Quest Diagnostics Recent Developments
Table 128. BD Corporation Information
Table 129. BD Description and Major Businesses
Table 130. BD Infectious Disease POC Diagnostic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 131. BD Infectious Disease POC Diagnostic Product Model Numbers, Pictures, Descriptions and Specifications
Table 132. BD Recent Developments
Table 133. bioMérieux Corporation Information
Table 134. bioMérieux Description and Major Businesses
Table 135. bioMérieux Infectious Disease POC Diagnostic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 136. bioMérieux Infectious Disease POC Diagnostic Product Model Numbers, Pictures, Descriptions and Specifications
Table 137. bioMérieux Recent Developments
Table 138. Cardinal Health Corporation Information
Table 139. Cardinal Health Description and Major Businesses
Table 140. Cardinal Health Infectious Disease POC Diagnostic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 141. Cardinal Health Infectious Disease POC Diagnostic Product Model Numbers, Pictures, Descriptions and Specifications
Table 142. Cardinal Health Recent Developments
Table 143. Cepheid Corporation Information
Table 144. Cepheid Description and Major Businesses
Table 145. Cepheid Infectious Disease POC Diagnostic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 146. Cepheid Infectious Disease POC Diagnostic Product Model Numbers, Pictures, Descriptions and Specifications
Table 147. Cepheid Recent Developments
Table 148. Trinity Biotech Corporation Information
Table 149. Trinity Biotech Description and Major Businesses
Table 150. Trinity Biotech Infectious Disease POC Diagnostic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 151. Trinity Biotech Infectious Disease POC Diagnostic Product Model Numbers, Pictures, Descriptions and Specifications
Table 152. Trinity Biotech Recent Developments
Table 153. Quidel Corporation Corporation Information
Table 154. Quidel Corporation Description and Major Businesses
Table 155. Quidel Corporation Infectious Disease POC Diagnostic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 156. Quidel Corporation Infectious Disease POC Diagnostic Product Model Numbers, Pictures, Descriptions and Specifications
Table 157. Quidel Corporation Recent Developments
Table 158. Bio-Rad Laboratories Corporation Information
Table 159. Bio-Rad Laboratories Description and Major Businesses
Table 160. Bio-Rad Laboratories Infectious Disease POC Diagnostic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 161. Bio-Rad Laboratories Infectious Disease POC Diagnostic Product Model Numbers, Pictures, Descriptions and Specifications
Table 162. Bio-Rad Laboratories Recent Developments
Table 163. Key Raw Materials Lists
Table 164. Raw Materials Key Suppliers Lists
Table 165. Infectious Disease POC Diagnostic Distributors List
Table 166. Infectious Disease POC Diagnostic Customers List
Table 167. Infectious Disease POC Diagnostic Market Trends
Table 168. Infectious Disease POC Diagnostic Market Drivers
Table 169. Infectious Disease POC Diagnostic Market Challenges
Table 170. Infectious Disease POC Diagnostic Market Restraints
Table 171. Research Programs/Design for This Report
Table 172. Key Data Information from Secondary Sources
Table 173. Key Data Information from Primary Sources
List of Figures
Figure 1. Infectious Disease POC Diagnostic Product Picture
Figure 3. Global Infectious Disease POC Diagnostic Market Share by Type in 2021 & 2028
Figure 3. Lateral Flow Immunoassay Product Picture
Figure 4. Agglutination Test Product Picture
Figure 5. Flow-Through Test Product Picture
Figure 6. Molecular Diagnostics Product Picture
Figure 7. Others Product Picture
Figure 8. Global Infectious Disease POC Diagnostic Market Share by Application in 2021 & 2028
Figure 9. Hospital Bedside
Figure 10. Urgent Care and Retail Clinics
Figure 11. Home and Self-Testing
Figure 12. Others
Figure 13. Infectious Disease POC Diagnostic Report Years Considered
Figure 14. Global Infectious Disease POC Diagnostic Sales 2017-2028 (K Units)
Figure 15. Global Infectious Disease POC Diagnostic Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 16. Global Infectious Disease POC Diagnostic Revenue 2017-2028 (US$ Million)
Figure 17. Global Infectious Disease POC Diagnostic Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 18. Global Infectious Disease POC Diagnostic Sales Market Share by Region (2017-2022)
Figure 19. Global Infectious Disease POC Diagnostic Sales Market Share by Region (2023-2028)
Figure 20. North America Infectious Disease POC Diagnostic Sales YoY (2017-2028) & (K Units)
Figure 21. North America Infectious Disease POC Diagnostic Revenue YoY (2017-2028) & (US$ Million)
Figure 22. Europe Infectious Disease POC Diagnostic Sales YoY (2017-2028) & (K Units)
Figure 23. Europe Infectious Disease POC Diagnostic Revenue YoY (2017-2028) & (US$ Million)
Figure 24. Asia-Pacific Infectious Disease POC Diagnostic Sales YoY (2017-2028) & (K Units)
Figure 25. Asia-Pacific Infectious Disease POC Diagnostic Revenue YoY (2017-2028) & (US$ Million)
Figure 26. Latin America Infectious Disease POC Diagnostic Sales YoY (2017-2028) & (K Units)
Figure 27. Latin America Infectious Disease POC Diagnostic Revenue YoY (2017-2028) & (US$ Million)
Figure 28. Middle East & Africa Infectious Disease POC Diagnostic Sales YoY (2017-2028) & (K Units)
Figure 29. Middle East & Africa Infectious Disease POC Diagnostic Revenue YoY (2017-2028) & (US$ Million)
Figure 30. The Infectious Disease POC Diagnostic Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 31. The Top 5 and 10 Largest Manufacturers of Infectious Disease POC Diagnostic in the World: Market Share by Infectious Disease POC Diagnostic Revenue in 2021
Figure 32. Global Infectious Disease POC Diagnostic Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 33. Global Infectious Disease POC Diagnostic Sales Market Share by Type (2017-2028)
Figure 34. Global Infectious Disease POC Diagnostic Revenue Market Share by Type (2017-2028)
Figure 35. Global Infectious Disease POC Diagnostic Sales Market Share by Application (2017-2028)
Figure 36. Global Infectious Disease POC Diagnostic Revenue Market Share by Application (2017-2028)
Figure 37. North America Infectious Disease POC Diagnostic Sales Market Share by Type (2017-2028)
Figure 38. North America Infectious Disease POC Diagnostic Revenue Market Share by Type (2017-2028)
Figure 39. North America Infectious Disease POC Diagnostic Sales Market Share by Application (2017-2028)
Figure 40. North America Infectious Disease POC Diagnostic Revenue Market Share by Application (2017-2028)
Figure 41. North America Infectious Disease POC Diagnostic Sales Share by Country (2017-2028)
Figure 42. North America Infectious Disease POC Diagnostic Revenue Share by Country (2017-2028)
Figure 43. United States Infectious Disease POC Diagnostic Revenue (2017-2028) & (US$ Million)
Figure 44. Canada Infectious Disease POC Diagnostic Revenue (2017-2028) & (US$ Million)
Figure 45. Europe Infectious Disease POC Diagnostic Sales Market Share by Type (2017-2028)
Figure 46. Europe Infectious Disease POC Diagnostic Revenue Market Share by Type (2017-2028)
Figure 47. Europe Infectious Disease POC Diagnostic Sales Market Share by Application (2017-2028)
Figure 48. Europe Infectious Disease POC Diagnostic Revenue Market Share by Application (2017-2028)
Figure 49. Europe Infectious Disease POC Diagnostic Sales Share by Country (2017-2028)
Figure 50. Europe Infectious Disease POC Diagnostic Revenue Share by Country (2017-2028)
Figure 51. Germany Infectious Disease POC Diagnostic Revenue (2017-2028) & (US$ Million)
Figure 52. France Infectious Disease POC Diagnostic Revenue (2017-2028) & (US$ Million)
Figure 53. U.K. Infectious Disease POC Diagnostic Revenue (2017-2028) & (US$ Million)
Figure 54. Italy Infectious Disease POC Diagnostic Revenue (2017-2028) & (US$ Million)
Figure 55. Russia Infectious Disease POC Diagnostic Revenue (2017-2028) & (US$ Million)
Figure 56. Asia Pacific Infectious Disease POC Diagnostic Sales Market Share by Type (2017-2028)
Figure 57. Asia Pacific Infectious Disease POC Diagnostic Revenue Market Share by Type (2017-2028)
Figure 58. Asia Pacific Infectious Disease POC Diagnostic Sales Market Share by Application (2017-2028)
Figure 59. Asia Pacific Infectious Disease POC Diagnostic Revenue Market Share by Application (2017-2028)
Figure 60. Asia Pacific Infectious Disease POC Diagnostic Sales Share by Region (2017-2028)
Figure 61. Asia Pacific Infectious Disease POC Diagnostic Revenue Share by Region (2017-2028)
Figure 62. China Infectious Disease POC Diagnostic Revenue (2017-2028) & (US$ Million)
Figure 63. Japan Infectious Disease POC Diagnostic Revenue (2017-2028) & (US$ Million)
Figure 64. South Korea Infectious Disease POC Diagnostic Revenue (2017-2028) & (US$ Million)
Figure 65. India Infectious Disease POC Diagnostic Revenue (2017-2028) & (US$ Million)
Figure 66. Australia Infectious Disease POC Diagnostic Revenue (2017-2028) & (US$ Million)
Figure 67. China Taiwan Infectious Disease POC Diagnostic Revenue (2017-2028) & (US$ Million)
Figure 68. Indonesia Infectious Disease POC Diagnostic Revenue (2017-2028) & (US$ Million)
Figure 69. Thailand Infectious Disease POC Diagnostic Revenue (2017-2028) & (US$ Million)
Figure 70. Malaysia Infectious Disease POC Diagnostic Revenue (2017-2028) & (US$ Million)
Figure 71. Latin America Infectious Disease POC Diagnostic Sales Market Share by Type (2017-2028)
Figure 72. Latin America Infectious Disease POC Diagnostic Revenue Market Share by Type (2017-2028)
Figure 73. Latin America Infectious Disease POC Diagnostic Sales Market Share by Application (2017-2028)
Figure 74. Latin America Infectious Disease POC Diagnostic Revenue Market Share by Application (2017-2028)
Figure 75. Latin America Infectious Disease POC Diagnostic Sales Share by Country (2017-2028)
Figure 76. Latin America Infectious Disease POC Diagnostic Revenue Share by Country (2017-2028)
Figure 77. Mexico Infectious Disease POC Diagnostic Revenue (2017-2028) & (US$ Million)
Figure 78. Brazil Infectious Disease POC Diagnostic Revenue (2017-2028) & (US$ Million)
Figure 79. Argentina Infectious Disease POC Diagnostic Revenue (2017-2028) & (US$ Million)
Figure 80. Colombia Infectious Disease POC Diagnostic Revenue (2017-2028) & (US$ Million)
Figure 81. Middle East and Africa Infectious Disease POC Diagnostic Sales Market Share by Type (2017-2028)
Figure 82. Middle East and Africa Infectious Disease POC Diagnostic Revenue Market Share by Type (2017-2028)
Figure 83. Middle East and Africa Infectious Disease POC Diagnostic Sales Market Share by Application (2017-2028)
Figure 84. Middle East and Africa Infectious Disease POC Diagnostic Revenue Market Share by Application (2017-2028)
Figure 85. Middle East and Africa Infectious Disease POC Diagnostic Sales Share by Country (2017-2028)
Figure 86. Middle East and Africa Infectious Disease POC Diagnostic Revenue Share by Country (2017-2028)
Figure 87. Turkey Infectious Disease POC Diagnostic Revenue (2017-2028) & (US$ Million)
Figure 88. Saudi Arabia Infectious Disease POC Diagnostic Revenue (2017-2028) & (US$ Million)
Figure 89. UAE Infectious Disease POC Diagnostic Revenue (2017-2028) & (US$ Million)
Figure 90. Infectious Disease POC Diagnostic Value Chain
Figure 91. Infectious Disease POC Diagnostic Production Process
Figure 92. Channels of Distribution
Figure 93. Distributors Profiles
Figure 94. Bottom-up and Top-down Approaches for This Report
Figure 95. Data Triangulation
Figure 96. Key Executives Interviewed

---